The market punishes Grifols despite quarterly profits
The Catalan pharmaceutical company falls on the stock market despite having increased its profits by 22%
BarcelonaThe distrust of investors with Grifols once again punishes the company's stock during earnings season. After the Catalan pharmaceutical company published its quarterly accounts at the close of Thursday's market, with a 22% increase in profit, up to 73 million euros, it opened Friday's stock session in a clear downward trend. Around twenty minutes to eleven in the morning, the Catalan multinational's shares are the worst in the selective index, with a decrease of more than 4%. Around midday, however, the analysis firm Moody's improved its assessment of the company's debt, painting a positive immediate future. With this new reading, the stock has rebounded slightly. After one in the afternoon, it lowered the value by about 2%, to 8.98 euros.
an increase in profit of 22%, to 73 million eurosConcern about proteins
The company's overall figures, according to analysts' initial reactions, have not been particularly concerning. Revenues have experienced a slight increase, of just over 3% if the dollar's devaluation is discounted. Free cash flow – the balance between cash inflows and outflows – closed in the negative, but the deficit has been reduced to only 8 million euros, well below the nearly 40 million from the first quarter of 2025.
However, some of the markets most closely watched by investors closed the first three months of the year with a decline. This is the protein segment, which includes strategic products for the Catalan company, such as Alfa-1 medications, which fell by 7.4% due to "a more demanding comparative base in 2025." The albumin market has also taken a step back, pressured by regulatory issues in China. In the meeting with analysts following the results presentation, Grifols' executives expressed optimism regarding these markets. Renta 4 bank expert Ana Gómez, however, indicates that the start of the year has been "sluggish" even within forecasts, and emphasizes that the currency effect due to the dollar's slump has "accentuated" the downward trend, also in this segment.